The versatility of Shigella effectors

Nature Reviews Microbiology

Volumn 6, Issue 1, 2008, Pages 11-16

  Ogawa, Michinaga ^a   Handa, Yutaka ^a   Ashida, Hiroshi ^a   Suzuki, Masato ^a   Sasakawa, Chihiro ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN ICSB; PROTEIN IPAA; PROTEIN IPAB; PROTEIN IPAC; PROTEIN IPAH; PROTEIN IPGB1; PROTEIN IPGD; PROTEIN OSPC1; PROTEIN OSPE2; PROTEIN OSPF; PROTEIN OSPG; PROTEIN VIRA; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGY; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; CELL CYCLE ARREST; CELL MOTILITY; CELL SPREADING; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE CRYPT; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; SHIGELLA; SHIGELLOSIS; SIGNAL TRANSDUCTION; TYPE III SECRETION SYSTEM;

ANIMALS; BACTERIAL PROTEINS; DYSENTERY, BACILLARY; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; SHIGELLA;

BACTERIA (MICROORGANISMS); SHIGELLA;

EID: 37349103988     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1814     Document Type: Article

References (40)

1. Ogawa, M. & Sasakawa, C. Intracellular survival of Shigella. Cell. Microbiol. 8, 177-184 (2006).
2. Sansonetti, P. J. & Di Santo, J. P. Debugging how bacteria manipulate the immune response. Immunity 26, 149-161 (2007).
3. Mattoo. S., Lee. Y. M. & Dixon, J. E. Interactions of bacterial effector proteins with host proteins. Curr. Opin. Immunol. 19, 392-401 (2007).
4. Cossart, P. & Sansonetti, P. J. Bacterial invasion: The paradigms of enteroinvasive pathogens. Science 304, 242-248 (2004).
5. Nhieu, G. T, Enninga, J., Sansonetti, P. & Grompone, G. Tyrosine kinase signaling and type III effectors orchestrating Shigella invasion. Curr. Opin. Microbiol. 8, 16-20 (2005).
6. Skoudy, A. et al. CD44 binds to the Shigella IpaB protein and participates in bacterial invasion of epithelial cells. Cell. Microbial. 2, 19-33 (2000).
7. 2 into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21, 5069-5078 (2002).
8. Pendaries, C. et al. Ptdins(5)P activates the host cell P13-kinase/Akt pathway during Shigella flexneri infection. EMBO J. 25, 1024-1034 (2006).
9. Bourdet-Sicard, R. et al. Binding of the Shigella protein IpaA to vinculin induces F-actin depolymerization. EMBO J. 18 5853-5862 (1999).
10. Demnali, K. A., Jue, A. L. & Burridge, K. IpaA targets βI integrins and rho to promote actin cytoskeleton rearrangements necessary for Shigella entry. J. Biol. Chem. 281, 39534-39541 (2006).
11. Handa, Y. et al. Shigella IpgB1 promotes bacterial entry through the ELMO-Dock 180 machinery. Nature Cell Biol. 9, 121-128 (2007).
12. Alto, N. M. et al. Identification of a bacterial type III effector family with G protein mimicry functions. Cell 124, 133-145 (2006).
13. Yoshida, S. et al. Shigella deliver an effector protein to trigger host microtubule destabilization, which promotes Rac1 activity and efficient bacterial internalization. EMBO J. 21, 2923-2935 (2002).
14. Matsuzawa, T., Kuwae, A., Yoshida, S., Sasakawa, C. & Abe, A. Enteropathogenic Escherichia coli activates the RhoA signaling pathway via the stimulation of GEF-H1. EMBO J. 23, 3570-3582 (2004).
15. Suzuki, T., Miki, H., Takenawa, T. & Sasakawa, C. Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri. EMBO J. 17, 2767-2776 (1998)
16. Pantaloni, D., Le Clainche, C. & Carlier, M. F. Mechanism of actin-based motility. Science 292, 1502-1506 (2001).
17. Yoshida, S. et al. Microtubule-severing activity of Shigella is pivotal for intercellular spreading. Science 314, 985-989 (2006).
18. Pfeuffer, T., Goebel, W., Laubinger, J., Bachmann, M. & Kuhn, M. LaXp180, a mammalian ActAbinding protein, identified with the yeast two-hybrid system, co-localizes with intracellular Listeria monocytogenes. Cell. Microbioil., 2, 101-114 (2000).
19. Mizushima, N. & Klionsky, D. J. Protein turnover via autophagy: implications for metabolism. Annu. Rev. Nutr. 27, 19-40 (2007).
20. Ogawa. M. et al. Escape of intracellular Shigella from autophagy. Science 307, 727-731 (2005).
21. Birmingham, C. L. et al. Lisberia monocytogenes, evades killing by autophagy during colonization of host cells. Autophagy 3, 442-451 (2007).
22. Fritz, J. H., Ferrero, R. L., Philpott, D. J. & Girardin, S. E. Nod-like proteins in immunity, inflammation and disease. Nature Immunol. 7, 1250-1257 (2006).
23. Ashida, H.. Toyotome, T., Nagai, T. & Sasakawa, C. Shigella chromosomal IpaH proteins are secreted via the type III secretion system and act as effectors. Mol. Microbial. 63, 680-693 (2007).
24. 9.8 binds to a splicing factor U2AF(35) to modulate host immune responses. Biochem. Biophys. Res Commun. 333, 531-539 (2005).
25. Rohde, J. R., Britkreutz. A., Chenal, A., Sansonetti, P. J. & Parsot, C. Type III secretion effectors of the IpaH family are E3 ubiquitin ligases. Cell Host Microbe 1, 77-83 (2007).
26. Kim, D. W. et al. The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes. Proc. Natl Acad. Sci. USA 102 14046-14051 (2005).
27. Arbibe, L. et al. An injected bacterial effector targets chromatin access for transcription factor NF-κB to alter transcription-of host genes involved in immune responses. Nature Immunol. 8, 47-56 (2007).
28. Kramer, R. W. et al. Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation. PLoS Pathog. 3, 179-190 (2007).
29. Zhang, J. et al. A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants. Cell Host Microbe 1, 175-185 (2007).
30. Nougayrede, J. P., Taieb, F., De Rycke, J. & Oswald, E. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 13, 103-110 (2005).
31. Oswald, E., Nougayrede, J. P., Taieb, F. & Sugai, M. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin, Microbiol. 8, 83-91 (2005).
32. Lara-Tejero, M. & Galan, J. E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 290, 354-357 (2000).
33. Gebert, B., Fischer, W., Weiss, E., Hoffmann, R. & Haas, R. helicobocter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science 301, 1099-1102 (2003).
34. Iwai, H. et al. A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell 130, 611-623 (2007).
35. Vondermaier, H. C. APC/C and SCF: Controlling each other and the cell cycle. Curr. Biol. 14, R787-R796 (2004).
36. Chen, Y., Smith, M. R., Thirumalai, K. & Zychlinsky, A. A bacterial invasin induces macrophage apoptosis by binding directly to ICE. EMBO J. 15, 3853-3860 (1996).
37. Nhieu. G. T., Caron. E., Hall, A. & Sansonetti. P. J. IpaC induces actin polymerization and filopodia formation during Shigella entry into epithelial cells. EMBO J. 18, 3249-3262 (1999).
38. Zurawski, D. V., Mitsuhata, C., Mumy, K. L., McCormick, B.A. & Maurelli, A. T. OspF and OspC1 are Shigella flexneri type III secretion system effectors that are required for postinvasion aspects of virulence. Infect. Immun. 74, 5964-5976 (2006).
39. Miura. M. et al. OspE2 of Shigella sonnei is required for the maintenance of cell architecture of bacterium-infected cells. Infect. Immun. 74, 2587-2595 (2006).
40. 7.8 facilitates escape of virulent bacteria from the endocytic vacuoles of mouse and human macrophages. Infect Immun. 68, 3608-3619 (2000).